Lawoko-Kerali et al. 2004. Dev Dyn. 231(4):801-14. PMID: 15499550
Alternate name:
US/VOT-N33; Ventral Otocyst-Neuroblast cell line number 33; University of Sheffield/Ventral OTocyst-Neuroblast 33; VOT-N33
Product description:
US/VOT-N33 Cell Line is a conditionally immortalized cell line representing migrating neuroblasts derived from the ventral otocyst of the Immortomouse™ at embryonic day 10.5 (E10.5). At this developmental stage, the sensory epithelia of the inner ear have not yet differentiated, and the ventral otocyst epithelium is competent to give rise to auditory neurons and epithelial cells. The cell line was established to model early inner ear development and mechanisms underlying hearing loss in mammals. The cells carry a stable insertion of the temperature-sensitive SV40 large T antigen (H-2Kb-tsA58) under the control of a γ-interferon-sensitive MHC Class I promoter, allowing conditional immortalization. The growth temperature and presence or absence of γ-interferon are critical for phenotype: Proliferating conditions: 33°C with γ-interferon Differentiating conditions: 39°C without γ-interferon The cell line has been extensively characterized using Affymetrix mouse microarrays and has demonstrated functional integration following transplantation to the cochlear nerve in vivo.
CRISPR:
No
Conditional:
Yes
Conditional description:
The cells were derived from ImmortomiceTM (Jat et al 1991 Proc. Nat. Acad. Sci. USA 88, 5096-5100) carrying a stable insertion of the conditional immortalising gene H-2Kb-tsA58, which describes a temperature-sensitive variant of the SV40 immortalising gene that encodes the large tumour antigen under the control of the γ–interferon-sensitive MHC Class 1 promoter. The cells proliferating culturing conditions: 33°C with γIFN; and the cells differentiating culturing conditions: 39°C without γIFN
Production details:
Homozygous male Immortomice™ (originally derived from injected oocytes of CBA/Ca × C57BL/10 mice) were time-mated with wild-type C57BL/6 female mice to produce heterozygous offspring. Embryos were harvested at E10.5, and ventral otocysts were dissected under sterile conditions. Explants were cultured in medium containing 50 U/mL γ-interferon at 33°C to support expression of the conditional immortalizing gene (H-2Kb-tsA58). Selection of explants was based on expression of tissue-specific markers, including the transcription factor GATA3, under differentiating conditions in vitro
Cellosaurus ID:
CVCL_VC37
Model description:
Conditionally immortalized cell line
Disease:
Deafness
Format:
Frozen
Storage conditions:
Liquid Nitrogen
Shipping conditions:
Dry ice
Growth medium:
MEM with 10% FCS, 50Units/ml y-IFN, L-glutamine, 33°C
Temperature:
33°C
Mycoplasma free:
Yes
Biosafety level:
1
References:
Sekiya et al. 2007. Eur J Neurosci. 25(8):2307-18. PMID: 17445229
Lawoko-Kerali et al. 2004. Dev Dyn. 231(4):801-14. PMID: 15499550
Human buccal mucosa modeling; Permeability, absorption and metabolism studies of various substances and enzymatically labile drugs; Drug delivery studies
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.